Sims Investment Management LLC Purchases New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

Sims Investment Management LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,032 shares of the healthcare conglomerate’s stock, valued at approximately $522,000. UnitedHealth Group comprises about 0.3% of Sims Investment Management LLC’s investment portfolio, making the stock its 25th biggest holding.

Several other large investors have also recently made changes to their positions in UNH. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $37,000. DecisionPoint Financial LLC increased its holdings in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 62 shares during the last quarter. Legacy Investment Solutions LLC purchased a new stake in UnitedHealth Group in the 3rd quarter worth about $57,000. Finally, FPC Investment Advisory Inc. increased its holdings in UnitedHealth Group by 863.6% in the 4th quarter. FPC Investment Advisory Inc. now owns 106 shares of the healthcare conglomerate’s stock worth $58,000 after acquiring an additional 95 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $474.95 on Friday. The stock has a market cap of $437.09 billion, a price-to-earnings ratio of 30.64, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock’s 50-day moving average is $516.59 and its 200 day moving average is $557.16.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $5.83 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be given a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.77%. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of several recent research reports. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Truist Financial cut their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. KeyCorp restated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.